Veronica Flood, MD 

Titles
Pediatric oncologist, Children's Hospital of Wisconsin; assistant professor, Medical College of Wisconsin.

Division
Hematology, Oncology and Transplant

Research interests
Bleeding and blood disorders, hemophilia, sickle cell anemia, genetic diseases/genomics.

Study interests
von Willebrand disease, hemophilia, thrombosis.

Education
Medical degree, Tufts University School of Medicine, Medford, Mass., 1999; residency, Phoenix Children's Hospital, 1999-2002; fellowship, Oregon Health and Science University, Portland, 2002-2005.

Certifications
Pediatrics, Pediatric Hermatology/Oncology.

Honors
Outstanding Research by a Pediatric Fellow Award, Doernbecher Children's Hospital, Portland, Ore., 2005; Chief Pediatric Fellow, Doernbecher Children's Hospital, Portland, Ore., 2004-2005; National Institutes of Health Individual Fellowship (National Research Service Award), 2004-2006; National Institutes of Health Loan Repayment Program for Pediatric Researchers, 2004-present; American Society of Hematology Clinical Research Training Institute, Dana Point, Calif., 2007.

Representative publications

• Flood VH, Johnson FL, Boshkov LK, Thomas GA, Bakke AC, Nugent DJ, Nicholson HS, Tilford D, Brown MP, Godder KT. Sustained Engraftment Post Bone Marrow Transplant Despite Anti-platelet Antibodies in Glanzmann Thrombasthenia. Pediatric Blood Cancer. 2005; 45(7):971-975.
• Flood VH, Al-Mondhiry HA, Farrell DH. The Fibrinogen A  R16C Mutation Results in Fibrinolytic Resistance. Br Journal Haematology. 2006; 134(2):220-226.
• Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH. Incorporation of Fibrin Molecules Containing Fibrinopeptide A Alters Clot Ultrastructure and Decreases Permeability. Br Journal Haematology. 2007; 138(1):117-124.
• Flood VH, Galderisi FC, Lowas SR, Kendrick A, Boshkov LK. Hemorrhagic Disease of the Newborn Despite Vitamin K Prophylaxis at Birth. Pediatric Blood Center. 2008; 50(5):1075-1077.
• Flood VH, Al-Mondhiry HA, Rein CM, Alexander KS, Lovely RS, Shackleton KM, David LL, Farrell DH. Fibrinogen Hershey IV: a Novel Dysfibrinogen with a gamma V4111 Mutation in the Integrin alpha(IIb)beta(3) Binding Site. Thromb Haemost. 2008; 99(6):1008-1012.

Grants

• Implications of von Willebrand Factor-Factor VIII Interactions, Hemophilia and Thrombosis Research Society, principal investigator.
• Studies of VWF Function in VWF-Platelet and VWF-FVIII Interactions, National Hemophilia Foundation, principal investigator.

Prior peer review

• Implications of von Willebrand Factor-Factor VIII Interactions, Children's Research Institute, principal investigator.
• Molecular Characterization of Human Dysfibrinogens, Tartar Trust Foundation, principal investigator.
• Molecular Characterization of a Human Dysfibrinogen, National Institutes of Health, principal investigator.

Non-peer review

• Molecular Characterization of Human Dysfibrinogens, Oregon Health and Sciences General Clinical Research Center, principal investigator.

Contact
Medical College of Wisconsin
8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 937-6896
Fax: (414) 937-3804
E-mail: veronica.flood@bcw.edu